Tag: vaccines

RFK Jr. Unloads Disturbing Vaccine Secrets on Tucker—And Surprises Everyone on Trump

It’s not every day an active HHS Secretary sits down for 90 minutes straight with Tucker Carlson.

But that’s exactly what happened, and Kennedy instantly seized Carlson’s attention with a chilling story of CDC corruption.

He revealed that the health agency buried a 1999 internal study led by researcher Thomas Verstraten, which showed an alarming 1135% increase in autism risk from the hepatitis B vaccine.

Kennedy said the researchers were “shocked” by the findings.

So what did they do? They covered it up, according to Kennedy.

“They got rid of all the older children essentially and just had younger children who are too young to be diagnosed [with autism].”

RFK Jr. then explained the real reason why your pediatrician will kick you out of their practice for refusing vaccines.

“There’s a published article out there now that says that 50% of revenues to most pediatricians come from vaccines.”

It’s all about the money. The higher the vaccination rate, the bigger the bonus.

“And that’s why your pediatrician, if you say I want to go slow on the vaccines… will throw you out of his practice because you’re now jeopardizing that bonus structure.”

Keep reading

New CDC Vaccine Panel Recommends Merck’s RSV Shot for All Newborns

Advisers to the Centers for Disease Control and Prevention (CDC) this morning voted to recommend all newborns receive Merck’s new monoclonal antibody shot, designed to protect against respiratory syncytial virus (RSV).

Two of the seven committee members, Retsef Levi, Ph.D., and Vicky Pebsworth, Ph.D., opposed the recommendation, citing safety concerns. The remaining five members supported it.

The vote marked the first — and closely watched — decision by the new members of the Advisory Committee on Immunization Practices (ACIP), appointed early this month by U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. He replaced all 17 sitting members, citing long-standing conflicts of interest that he said had plagued the committee for years.

Kennedy’s decision outraged the mainstream public health industry, which feared the new committee would be more critical of vaccines. It even prompted a move by vaccine manufacturers, insurers and the professional medical organizations they support to bypass government health agencies’ recommendations by creating a nongovernmental system for recommending and purchasing vaccines.

The U.S. Food and Drug Administration earlier this month approved Merck’s RSV shot, clesrovimab, which will be marketed as Enflonsia. It joins two other recently approved RSV drugs. One is Sanofi and AstraZeneca’s monoclonal antibody shot for infants, Beyfortus (nirsevimab). The other is Pfizer’s RSV vaccine, Abrysvo, for pregnant mothers.

Data presented by the CDC during Wednesday’s ACIP meeting reassured committee members that the recently approved RSV interventions were safe and effective.

However, an analysis of the CDC’s Vaccine Safety Datalink for the 2023-2024 respiratory season revealed an association between Abrysvo and an increased risk for hypertensive disorders of pregnancy, which include gestational hypertension, preeclampsia, eclampsia and HELLP syndrome, a life-threatening pregnancy complication.

Presenters repeatedly emphasized that RSV — a common respiratory virus that usually causes mild cold-like symptoms but can be serious in infants — is the leading cause of hospitalization for infants in the U.S. There are fewer than 100 deaths per year from RSV in the U.S., according to data presented at the meeting.

Keep reading

Nearly 10,000 Claims Pending as COVID Vaccine Injury Compensation Program Faces Possible Budget Cut

A government-run COVID-19 vaccine injury compensation program with nearly 10,000 pending claims faces the threat of a budget cut for the 2026 fiscal year.

The Trump administration’s proposed budget would eliminate funding for the Countermeasures Injury Compensation Program (CICP), TrialSite News reported last week. If approved, the program would be forced to operate on “carryover funds” — or unspent funds from previous years.

According to TrialSite News:

“With no civil court recourse under the PREP Act, downgrading CICP funding leaves injured individuals with limited legal avenues and uncertain financial relief. This undermines public trust in vaccine policy, risks fueling hesitancy, and may deter future claim filings altogether.

“The decision to drop new CICP funding was hidden in budget pages — no public announcements or detailed breakdown of carryover metrics. How much carryover exists? How long will it last? What if claim volume increases?”

CICP was established under the Public Readiness and Emergency Preparedness Act (PREP Act) of 2005.

Under a PREP Act declaration, issued during an official public health emergency such as the COVID-19 pandemic, manufacturers of vaccines and other countermeasures associated with a health emergency are exempt from liability for serious injuries or death caused by their products — except in cases of willful misconduct.

That means people who believe they were injured by one of these products can’t sue the manufacturer. Instead, they can apply to the CICP for compensation.

However, even if successful, claimants often receive limited compensation from CICP. By law, the program can reimburse only those medical expenses not compensated by insurance or other programs.

It can also reimburse for lost employment income (capped at $50,000 per year) and a one-time benefit of $370,000 for deaths.

The program does not reimburse legal fees or provide compensation for pain and suffering.

Keep reading

ACIP Members Push Back on CDC’s COVID Vaccine Safety Claims

The Centers for Disease Control and Prevention’s (CDC) COVID-19 vaccine work group today assured the agency’s new panel of vaccine advisers that the vaccines are necessary, effective and have no safety concerns beyond a small risk of myocarditis among an age-limited group of young men.

The new members of the Advisory Committee on Immunization Practices (ACIP) pushed back on several claims made by the presenters, including the agency’s methods for assessing efficacy and safety.

They also questioned claims the group made about how dangerous the COVID-19 virus is, especially for children.

ACIP didn’t schedule a vote today on COVID-19 vaccines. The committee only heard data presentations by the work group and engaged in a question-and-answer session.

Today’s meeting was the first since U.S. Health and Human Services Secretary Robert F. Kennedy Jr. fired the previous 17 ACIP members and replaced them with eight (now seven) new members.

The work group members haven’t changed under the new administration.

Last month, Kennedy announced changes to the COVID-19 vaccination recommendations for children and pregnant women.

The CDC now recommends “shared clinical decision-making” between parents and providers for healthy children ages 6 months to 17 years who are not moderately immunocompromised. The agency changed its guidance on COVID-19 vaccines for pregnant women from recommended to “no guidance.”

After several hours of presentations, the work group concluded that the 2024-2025 vaccines were effective in preventing hospitalizations and critical outcomes from COVID-19 in adults, that there is robust safety surveillance with no known risks beyond myocarditis.

The group also concluded that pregnant women are at greater risk from COVID-19, and that maternal vaccination has been shown to protect infants — a claim unsupported by any data from the presentations, said Dr. Meryl Nass, who live-blogged the meeting for CHD.TV.

Keep reading

CDC Advisers Vote To Recommend Removal Of Mercury From Influenza Vaccines

Advisers to the Centers for Disease Control and Prevention on June 26 advised the agency to stop recommending influenza vaccines containing a mercury-based preservative.

The Advisory Committee on Immunization Practices (ACIP) in a series of votes reaffirmed the existing recommendation that virtually all individuals aged at least 6 months of age receive an annual influenza shot. The panel further advised, though, that individuals only receive thimerosal-free vaccines.

About 95 percent of influenza vaccines administered in the United States in late 2024 and early 2025 were free of thimerosal, according to the Food and Drug Administration. Dr. Tracy Hoeg, an FDA official, told the committee that there appear to be enough influenza vaccine doses without thimerosal for the upcoming virus season, which runs from the fall into the winter.

A spokesperson for Sanofi told The Epoch Times in an email: “We acknowledge the recommendation of the new ACIP. We now await the decision by the CDC on the path forward.

“We will have sufficient supply of Sanofi flu vaccine to support customer preference for this season.”

Seqirus, which also produces influenza vaccines with thimerosal, has not responded to requests for comment.

ACIP provides advice to the CDC’s director, who typically adopts the recommendations.

The CDC has no acting director listed on its website. President Donald Trump’s nominee for the post, Susan Monarez, is being considered by the Senate. The CDC and its parent agency, the Department of Health and Human Services, did not respond to requests for comment.

Health Secretary Robert F. Kennedy Jr. earlier in the year adopted some recommendations offered by ACIP.

Kennedy has long opposed vaccines with thimerosal, and the panel heard before the vote from Lyn Redwood, a past president of a nonprofit that Kennedy founded who is now listed as an employee of the Department of Health and Human Services.

Redwood said in her presentation that a number of studies have provided evidence against thimerosal, including a 2003 paper that found an association between thimerosal exposure and tics and a 2007 study that found links to several positive and several negative associations, including a lower measure of executive functioning.

“There have been studies that have found evidence of harm,” Redwood said.

Keep reading

More Fetal Losses Than Expected After Pfizer COVID-19 Vaccination In Israel: Study

A higher-than-expected number of miscarriages and other forms of fetal loss were associated with COVID-19 vaccinations in Israel, a new study has revealed.

Researchers found 13 fetal losses—four more than the nine expected—for every 100 pregnant women who received a COVID-19 vaccine during weeks eight to 13 in pregnancy, according to the study, which was published as a preprint on the medRxiv server.

Most people in Israel, including pregnant women, received the Pfizer-BioNTech COVID-19 vaccine.

Pfizer did not respond by publication time to a request for comment.

The team behind the study includes Retsef Levi, a Massachusetts Institute of Technology researcher who was recently named to the committee that advises the Centers for Disease Control and Prevention on vaccines, and Dr. Tracy Hoeg, who works for the Food and Drug Administration.

The researchers analyzed electronic health records from Maccabi Healthcare Services, one of four organizations that provide health care to Israelis. They looked at 226,395 pregnancies that occurred between March 1, 2016, and Feb. 28, 2022. The primary analysis looked at fetal loss for pregnant women after dose one or dose three of a COVID-19 vaccine, with fetal loss including miscarriage, abortion, and stillbirth.

The researchers came up with an expected number of fetal losses based on a model that drew from data before the COVID-19 pandemic, then compared the expected number of fetal losses with those that occurred from week eight of pregnancy onward.

They identified 13,214 fetal losses after the COVID-19 pandemic started, compared with 12,846 fetal losses in the reference period, finding that women who received a COVID-19 vaccine during weeks eight to 13 in pregnancy experienced a higher-than-expected number of fetal losses.

“If you believe this result … every 100 women that you would vaccinate during weeks eight to 13, you are going to see close to four additional fetal losses,” Levi told The Epoch Times.

Keep reading

RFK Jr. Axes ALL Funding for Bill Gates’ Global ‘Vaccine Alliance’

Whereas the general modus operandi in legacy media is to smear RFK Jr. as an “anti-vaxxer” within the first sentence, the Washington Post courteously waited until the second paragraph to label RFK Jr. a “vaccine misinformation” spreader on its way to condemning him for cutting federal funding to Bill Gates’ global “vaccine alliance,” GAVI.

Via Washington Post (emphasis added):

The United States will halt its contributions to Gavi, the global alliance that works to expand access to vaccines for children in some of the world’s poorest countries, said Health and Human Services Secretary Robert F. Kennedy Jr. Wednesday — a move that public health experts said would have deadly consequences.

Kennedy, who has a history of spreading vaccine misinformation, announced the decision in video remarks made to a Gavi summit in Brussels, during which he accused the group of neglecting “the key issue of vaccine safety.”…

In his remarks, Kennedy cited a study linking the DTP vaccine — for diphtheria, a highly contagious bacterial infection that kills 5 to 10 percent of those affected, as well as tetanus and pertussis — to increased child mortality. Kennedy also said Gavi should “consider the best science available,” and “re-earn the public trust.”

Keep reading

SARS-CoV-2 Vaccination and the Multi-Hit Hypothesis of Oncogenesis

Cancer is a complex and dynamic disease. The “hallmarks of cancer” were proposed by Hanahan and Weinberg (2000) as a group of biological competencies that human cells attain as they progress from normalcy to neoplastic transformation. These competencies include self-sufficiency in proliferative signaling, insensitivity to growth-suppressive signals and immune surveillance, the ability to evade cell death, enabling replicative immortality, reprogramming energy metabolism, inducing angiogenesis, and activating tissue invasion and metastasis. Underlying these competencies are genome instability, which expedites their acquisition, and inflammation, which fosters their function(s). Additionally, cancer exhibits another dimension of complexity: a heterogeneous repertoire of infiltrating and resident host cells, secreted factors, and extracellular matrix, known as the tumor microenvironment, that through a dynamic and reciprocal relationship with cancer cells supports immortality, local invasion, and metastatic dissemination. This staggering intricacy calls for caution when advising all people with cancer (or a previous history of cancer) to receive the COVID-19 primary vaccine series plus additional booster doses. Moreover, because these patients were not included in the pivotal clinical trials, considerable uncertainty remains regarding vaccine efficacy, safety, and the risk of interactions with anticancer therapies, which could reduce the value and innocuity of either medical treatment.

After reviewing the available literature, we are particularly concerned that certain COVID-19 vaccines may generate a pro-tumorigenic milieu (i.e., a specific environment that could lead to neoplastic transformation) that predisposes some (stable) oncologic patients and survivors to cancer progression, recurrence, and/or metastasis. This hypothesis is based on biological plausibility and fulfillment of the multi-hit hypothesis of oncogenesis (i.e., induction of lymphopenia and inflammation, downregulation of angiotensin-converting enzyme 2 (ACE2) expression, activation of oncogenic cascades, sequestration of tumor suppressor proteins, dysregulation of the RNA-G quadruplex-protein binding system, alteration of type I interferon responses, unsilencing of retrotransposable elements, etc.) together with growing evidence and safety reports filed to Vaccine Adverse Effects Report System (VAERS) suggesting that some cancer patients experienced disease exacerbation or recurrence following COVID-19 vaccination. In light of the above and because some of these concerns (i.e., alteration of oncogenic pathways, promotion of inflammatory cascades, and dysregulation of the renin-angiotensin system) also apply to cancer patients infected with SARS-CoV-2, we encourage the scientific and medical community to urgently evaluate the impact of both COVID-19 and COVID-19 vaccination on cancer biology and tumor registries, adjusting public health recommendations accordingly.

Keep reading

The Hidden Tragedy of Neurological Vaccine Injuries

From birth, we are taught that vaccines were one of the most remarkable discoveries in history, and were so safe and effective that many now unimaginable plagues vanished with few to no side effects occurring in the process. In truth, give or take, every part of that mythology is false, and remarkably similar vaccine disasters occur every few decades.

Much of this results from the fact that it is very difficult to produce safe vaccines due to both their mode of action and the methods used in their production. As such, the best “solution” which could be found to this problem was to insist in lockstep that vaccines were safe and erase any memory that vaccine disasters had in fact occurred, thereby making it possible to gaslight anyone who was severely injured by a vaccine and claim their injury was just anecdotal or a product of anti-vaccine hysteria.

For example, recently I discussed how vaccines cause autism, and focused on a central argument used to debunk the link between the two—that the only reason people believe vaccines cause autism is because a disgraced British doctor published a fraudulent 1998 study claiming they did and then made everyone start hallucinating that vaccine injuries were occurring.

This mythology however, ignores that brain injuries were a longstanding problem of vaccination. For example, a 1982 NBC news program revealed that many parents were having children develop “post-pertussis encephalopathy” after taking the DPT vaccine, that most doctors refused to report this.

Keep reading

CDC’s New Vaccine Advisers Vow to Study Cumulative Effect of Childhood Vaccine Schedule

The CDC’s new advisory committee today announced plans to look at the cumulative effect of all vaccines given during childhood.

Martin Kulldorff, Ph.D., the committee’s new co-chair, said:

“The number of vaccines that our children and adolescents receive today exceeds what children in most other developed nations receive — and what most of us in this room received when we were children.

“In addition to studying and evaluating individual vaccines, it is important to evaluate the cumulative effect of the recommended vaccine schedule. This includes interaction effects between different vaccines, the total number of vaccines, cumulative amounts of vaccine ingredients, and relative timing of different vaccines.”

A new committee work group will look into these issues, Kulldorff said. The Centers for Disease Control and Prevention currently recommends at least 70 doses of 15 different vaccines for children and adolescents up to age 18.

Another new work group will look at vaccines that have not been subject to reviewed in more than seven years, he added. “This was supposed to be a regular practice of the ACIP, but it has not been done in a thorough and systematic way. We will change that.”

ACIP began its two-day meeting today despite a call from Sen. Bill Cassidy (R-La.) late Monday to delay the meeting until the committee “is fully staffed with more robust and balanced representation.”

On June 11, U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. named eight researchers and physicians to the Centers for Disease Control and Prevention’s (CDC) vaccine advisory panel, two days after removing all 17 ACIP sitting members.

However, according to The New York Times, one of the new members, Dr. Michael A. Ross, a physician licensed in Virginia and a former professor of obstetrics and gynecology, withdrew from the committee.

Kennedy reconstituted the committee to “avoid conflicts of interest,” citing past members’ financial ties to pharmaceutical companies, he said in a Wall Street Journal op-ed about the change.

According to Cassidy, although the new committee members “have scientific credentials, many do not have significant experience studying microbiology, epidemiology or immunology. In particular, some lack experience studying new technologies such as mRNA vaccines, and may even have a preconceived bias against them.”

Keep reading